15
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Effect of 5-Aminosalicylic Acid and Analogous Substances on Superoxide Generation and Intracellular Free Calcium in Human Neutrophilic Granulocytes

, , &
Pages 527-532 | Received 06 Jul 1992, Accepted 12 Oct 1992, Published online: 08 Jul 2009

References

  • Nielsen O H. In vitro studies on the significance of arachidonate metabolism and other oxidative processes in the inflammatory response of human neutrophils and macrophages-with special reference to chronic inflammatory bowel disease. Scand J Gastroenterol 1998; 23(Suppl 150)1–21
  • Stenson W F, MacDermott R P. Immunology of inflammatory bowel disease. Year Immunol 1989; 4: 286–95
  • Ligumsky M, Simon P L, Karmeli F, Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut 1990; 31: 686–9
  • Nielsen O H, Ahnfelt-Rønne I. Involvement of oxygen-derived free radicals in the pathogenesis of chronic inflammatory bowel disease. Klin Wochenschr 1991; 69: 995–1000
  • Williams J G, Hughes L E, Hallett M B. Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease. Gut 1990; 31: 187–93
  • Grishamm M B, Granger D N. Neutrophil-mediated mucosal injury: role of reactive oxygen metabolites. Dig Dis Sci 1988; 33(Suppl 3)67–15
  • Zipser R D, Dinarello C A. Sulfasalazine inhibits cytokine production in human mononuclear cells: a novel anti-inflammatory mechanism. Gastroenterology 1988; 96: A96
  • Mahida Y R, Lamming C ED, Gallagher A, Hawthorne A B, Hawkey C J. 5-aminosalicylic acid is a potent inhibitor of interleukin 1β production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease. Gut 1991; 32: 50–4
  • Ahnfelt-Rønne I, Nielsen O H. The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger. Agents Actions 1987; 21: 191–4
  • Ahnfelt-Rønne I, Nielsen O H, Christensen A, Langholz E, Binder V, Riis P. Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. Gastroenterology 1990; 98: 1162–9
  • Roediger W, Schapel G, Lawson M, Radcliffe B, Nance S. Effect of 5-amino-salicylic acid (5-ASA) and other salicylates on short-chain fat metabolism in the colonic mucosa. Biochem Pharmacol 1989; 35: 221–5
  • Dull B J, Salata K, Langenhove A V, Goldman P. 5-aminosalicylate: oxidation by activated leukocytes and protection of cultured cells from oxidative damage. Biochem Pharmacol 1987; 36: 2467–72
  • Aruoma O I, Wasil M, Halliwell B, Hoey B M, Butler J. The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects. Biochem Pharmacol 1987; 36: 3739–42
  • Miyachi Y, Yoshioka A, Imamura S, Niwa Y. Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species. Gut 1987; 28: 190–5
  • Carlin G, Djursäter R, Smedegård G. Inhibitory effects of sulfasalazine and related compounds on superoxide production by human polymorphonuclear leukocytes. Pharmacol Toxicol 1989; 65: 121–7
  • Williams J G, Hallett M B. Effect of sulphasalazine and its active metabolite, 5-amino-salicylic acid, on toxic oxygen metabolite production by neutrophiis. Gut 1989; 30: 1581–7
  • Tamai H, Kachur J F, Grisham M B, Gaginella T S. Scavenging effect of 5-aminosalicylic acid on neutrophil-derived oxidants. Biochem Pharmacol 1991; 41: 1001–6
  • Smith C D, Cox C C, Snyderman R. Receptor-coupled activation of phosphoinositide-specific phospholipase C by an N protein. Science 1986; 232: 97–100
  • Badwey J A, Karnovsky M L. Production of superoxide by phagocytic leukocytes: a paradigm for stimulus-response phenomena. Curr Top Cell Regul 1986; 28: 183–208
  • Böyum A. Isolation of leucocytes from human blood. Scand J Clin Lab Invest 1968; 21(Suppl 97)9–29
  • DeRenzis F A, Schechtman A. Staining by neutral red and trypan blue in sequence for assaying vital and nonvital cultured cells. Stain Technol 1973; 48: 135–6
  • McCord J M, Fridovich I. Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 224: 6049–63
  • Bromberg Y, Pick E. Activation of NADPH-dependent production in a cell-free system by sodium dodecyl sulfate. J Biol Chem 1985; 260: 13539–45
  • Gyllenhammar H. Correlation between neutrophil superoxide formation, luminol-augmented chemiluminescence and intracellular Ca2+ levels upon stimulation with leukotriene B4, for-mylpeptide and phorbolester. Scand J Clin Lab Invest 1989; 49: 317–22
  • Bouchelouche P N, Berild D. Possible existence of leukotriene D4 receptors and mechanism of their signal transduction in human polymorphonuclear leukocytes. Scand J Clin Lab Invest 1991; 51(Suppl 204)47–55
  • Blinks J R, Wier W G, Hess P, Prendergast F G. Measurement of Ca24 concentrations in living cells. Prog Biophys Mol Biol 1982; 40: 1–114
  • Tsien R Y, Rink T J, Poenie M. Measurement of cytosolic free Ca2+ in individual small cells using fluorescence microscopy with dual excitation wavelengths. Cell Calcium 1985; 6: 145–53
  • Grynkiewicz G, Poenie M, Tsien R Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440–50
  • Keshavarzian A, Morgan G, Sedghi S, Gordon J H, Doria M. Role of reactive oxygen metabolites in experimental colitis. Gut 1990; 31: 786–90
  • Ahnfelt-Rønne I. Rationales for drug development in inflammation: Eicosanoids and oxygen-derived free radicals. Dan Med Bull 1991; 38: 291–303
  • Emerit J, Loeper J, Chomette G. Superoxide dismutase in the treatment of postradiotherapeutic necrosis and of Crohn's disease. Bull Eur Physiopathol Respir 1981; 17(Suppl)287–8
  • Niwa Y, Somiya K, Michelson A M, Puget K. Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related human disorders. A preliminary study. Free Radic Res Commun 1988; 1: 137–53
  • Kitahora T, Suzuki K, Asakura H. Active oxygen species generated by monocytes and polymorphonuclear cells in Crohn's disease. Dig Dis Sci 1988; 33: 951–5
  • Wandall J H. Effects of sulfasalazine and its metabolites on neutrophil chemotaxis, superoxide production, degranulation and translocation of cytochrome b-245. Aliment Pharmacol Ther 1991; 5: 609–19
  • Bondesen S, Nielsen O H, Schou J B. Steady-state kinetics of 5-aminosalicylic acid and sulfapyridine during sulfasalazine profylaxis in ulcerative colitis. Scand J Gastroenterol 1986; 21: 693–700
  • Anderson T, Dahlgren C, Lew P D, Stendahl O. Cell surface expression of f-met-leu-phe receptors on human neutrophiis: correlation to changes in the cytosolic free Ca2+ level and action of phorbol myristate acetate. J Clin Invest 1987; 79: 1226–33
  • O'Flaherty J T, Rossi A G, Jacobson D P, Fredman J F. Roles of Ca2+ in human neutrophil responses to receptor agonists. Biochem J 1991; 278: 705–11
  • Grinstein S, Furuya W. Receptor-mediated activation of electropermeabilized neutrophiis. Evidence for a Ca2+ and proteinkinase C-independent signaling pathway. J Biol Chem 1988; 263: 1779–83
  • Lew P D, Monod A, Waldvogel F A, Pozzan T. Role of cytosolic free calcium and phospholipase C in leukotriene B4 stimulated secretion in human neutrophiis. Comparison with the chemotactic peptide formyl-methionyl-leucyl-phenylalanine. Eur J Biochem 1987; 162: 161–8
  • Kanerud L, Hafström I, Ringertz B. Effect of sulphasalazine and sulphapyridine on neutrophil superoxide production: role of cytosolic free calcium. Ann Rheum Dis 1990; 49: 296–300
  • Shaafi R I, White J R, Molski T FP. Phorbol 12-myristate 13-acetate activates rabbit neutrophiis without an apparent rise in the level of intracellular free calcium. Biochem Biophys Res Commun 1983; 114: 638–45
  • Stenson W F, Mehta J, Spilberg I. Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (fMLP) to its receptor on human neutrophiis. Biochem Pharmacol 1984; 33: 407–12
  • Nielsen O H, Ahnfelt-Rønne I. Involvement of oxygen-derived free radicals in the pathogenesis of chronic inflammatory bowel disease. Klin Wochenschr 1991; 69: 995–1000

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.